Photo courtesy of Stephan Schwander
Three student teams were named winners of the first-ever Global Health Case Competition, a 10-week experience focused on the impact of COVID-19 on underserved communities in New Jersey.
On Rutgers Giving Day, a 24-hour fundraising event, Rutgers Global Health Institute raised $18,870 to help confront health disparities in New Jersey.
It’s been a year since COVID-19 was declared a global pandemic. Rutgers Global Health Institute core faculty members discuss the health crisis in relation to their own areas of expertise and professional practice.
On Rutgers Giving Day, March 24, Rutgers Global Health Institute will seek support for its new Health Equity in New Jersey Fund.
In an interview with The Daily Targum, institute director Richard Marlink explains the international collaboration to distribute COVID-19 vaccines more equitably worldwide.
Rutgers Global Health Institute Launches Program to Help Small Businesses Impacted by the COVID-19 Pandemic
The three-part program provides guidance on safe operations and related support services for small businesses and nonprofits in New Jersey’s low-income and minority communities.
Following the FDA’s emergency approval of Johnson & Johnson’s COVID-19 vaccine, ROI-NJ published a collection of health experts’ perspectives that includes institute director Richard Marlink’s comments about vaccine efficacy.
The dashboard, which displays information to help state residents, stakeholders, and policy makers understand the range of services available to youth and families, comes at a critical time. The pandemic continues to impact children and youth, who face increased levels of anxiety, stress, isolation, and a sense of loss and grief.
The importance of a global COVID-19 vaccination strategy and how WHO involvement benefits the U.S. overall are topics that institute director Richard Marlink discusses in this Q&A.
Appearing on CNBC’s Power Lunch, core faculty member and Rutgers vice chancellor Reynold Panettieri discusses the Johnson & Johnson COVID-19 vaccine, infection rates and hospitalizations, and effective public health measures.